Indications
RIMSO-50 ® (dimethyl sulfoxide) is indicated for the symptomatic relief of patients with interstitial cystitis. RIMSO-50 ® has not been approved as being safe and effective for any other indication. There is no clinical evidence of effectiveness of dimethyl sulfoxide in the treatment of bacterial infections of the urinary tract.
Contraindications
None known.
Warnings and precautions
Dimethyl sulfoxide can initiate the liberation of histamine and there has been occasional hypersensitivity reaction with topical administration of dimethyl sulfoxide. This hypersensitivity has been reported in one patients receiving intravesical RIMSO-50 ® . The physician should be cognizant of this possibility in prescribing RIMSO-50 ® . If anaphylactoid symptoms develop, appropriate therapy should be instituted.
Adverse reactions
A garlic-like taste may be noted by the patient within a few minutes after instillation of RIMSO-50 ® (dimethyl sulfoxide). This taste may last several hours and because of the presence of metabolites, an odor on the breath and skin may remain for 72 hours. Transient chemical cystitis has been noted following instillation of dimethyl sulfoxide. The patient may experience moderately severe discomfort on administration.
Usually this becomes less prominent with repeated administration.
Composition
- Active ingredients
- DIMETHYL SULFOXIDE 50%
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA017788.
At a glance
- Brand name
- Rimso-50
- Active substance
- dimethyl sulfoxide
- Route
- Into the bladder
- Dosage form
- Solution
- Applicant
- Mylan Institutional
- Status
- Prescription
- FDA approval
- 4 Apr 1978
- Application
- NDA017788-001



